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Abstract
Background: One of the characteristics of inflammation is swelling or edema. Inflammation can be treated 
with traditional medicine, such as Bixa orellana L. Bixa orellana L leaf  contains flavonoid and tannin 
responsible for its anti-inflammatory effect. This study was conducted to analyse the ability of Bixa orellana 
L leaf infusion (BOLI) to suppress paw edema in carrageenan-induced Wistar rats.
Methods: This study was conducted in the Animal Laboratory of Department of Pharmacology and Therapy 
Faculty of Medicine Universitas Padjadjaran in October 2012. Bixa orellana L leaves were procured from 
Lembang, Bandung, and were botanically identified at the Herbarium of Universitas Padjadjaran, Jatinangor. 
Thirty female Wistar rats were randomly divided into five groups. Group 1 was given 5 mL aquades as a 
control, three groups received BOLI with 0,09 g; 0,18 g; and 0,36 g dosage respectively; and group 5 was given 
0,9 mg diclofenac. At 1 hour after treatment, all rats were induced by carrageenan injection subcutaneously. 
Paw edema changes were quantified at 0, 1, 2, 3, 4, 5, 6, and 24 hour afterwards. Data were analysed using 
Kruskal-Wallis and Mann-Whitney test
Results: Based on paw edema inhibition percentage, 0.18 g of BOLI was shown most effective (16.97%) 
compared to 0.09 g (10.96%) and 0.36 g (7.50%). Interestingly, no significant differences of anti-inflammatory 
effect were observed between groups that were treated with 0,18 g of BOLI and diclofenac (p > 0,005).
Conclusions: The BOLI with effective dosage 0.18 g (equivalent with 200 g bodyweight/day) suppress 
inflammation comparable to diclofenac. [AMJ.2014;1(2):60–4]
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Infusa Daun Kesumba (Bixa Orellana L) sebagai Anti Inflamasi pada 
Tikus Wistar yang Diinduksi Carrageenan
Abstrak
Latar Belakang: Salah satu ciri khas dari peradangan atau inflamasi adalah adanya pembengkakan atau 
edema. Peradangan dapat diobati  dengan obat tradisional, seperti Kesumba (Bixa orellana). Daun Kesumba 
diketahui mengandung flavonoid dan tanin yang berfungsi sebagai anti-inflamasi. Penelitian ini dilakukan 
untuk menganalisis kemampuan infusa daun kesumba (Bixa orellana) (BOLI) dalam mengurangi edema 
tungkai pada kaki tikus Wistar yang diinduksi Carrageenan.
Metode: Penelitian ini dilakukan di Laboratorium Hewan Departemen Farmakologi dan Terapi di Rumah 
Sakit Umum Dr. Hasan Sadikin Bandung pada bulan Oktober 2012. Daun Kesumba (Bixa Orellana L) diperoleh 
dari Lembang, Bandung, dan diidentifikasi botani di Herbarium Universitas Padjadjaran, Jatinangor. Tiga 
puluh tikus Wistar betina secara acak dibagi menjadi lima kelompok. Kelompok 1 diberi 5 mL aquades 
sebagai kontrol, tiga kelompok menerima BOLI dengan 0,09 g; 0,18 g; dan masing-masing 0,36 g dosis; dan 
kelompok 5 diberi 0,9 mg diklofenak. Pada 1 jam setelah pengobatan, semua tikus diinduksi oleh subkutan 
injeksi karagenan. Perubahan edema tungkai diukur pada 0, 1, 2, 3, 4, 5, 6, dan 24 jam sesudah pengobatan. 
Data dianalisis dengan menggunakan Kruskal-Wallis dan uji Mann-Whitney.
Hasil: Berdasarkan persentase pengurangan edema tungkai, kelompok 0,18g BOLI terlihat paling efektif 
(16,9%) dibandingkan dengan 0,09 g (10,9%) dan 0,36 g (7,5%). Tidak ada perbedaan yang signifikan dari 
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efek anti-inflamasi yang diamati antara kelompok-kelompok yang diobati dengan 0,18 g BOLI dan diklofenak 
(p> 0.005).
Simpulan: Infusa Daun Kesumba (BOLI) dengan dosis efektif 0,18 g (setara dengan 200 g berat badan / 
hari) menekan peradangan sama baik dibandingkan dengan diklofenak. [AMJ.2014;1(2):60–4]
Kata kunci: anti-inflamasi, daun kesumba (Bixa orellana L), edema 
Introduction
Inflammation is a protective response invoked 
in organisms towards alteration in normal 
tissues. It has five main characteristics, which 
are rubor (redness), tumor (swelling), calor 
(heat), dolor (pain), and functiolaesa (loss of 
function). Chronic inflammation can cause rheumatoid arthritis, atherosclerosis, and 
tuberculosis. Therefore, anti-inflammatory drugs, both steroidal and non-steroidal, play a pivotal role in taking the response under control.1 
Bixa orellana L, the so-called “lipstick tree” 
from Bixaceae family, has been approved safe for human consumption by the Food and 
Drug Administration (FDA) of the USA. It is 
beneficial intreating fever, stomachache, sore throat, burn injury, and epilepsy pertaining 
to its anti-inflammatory effect.3 A Previous 
study) using Bixa orellana L leaf extract proved 
flavonoid and tannin in favor of that advantage. Moreover, there are some other chemical 
compounds found within Bixa orellana L leaf, 
for instance sterol, saponin, and ishwarane.4 
This study was conducted to analyse the 
anti-inflammatory effect of Bixa orellana 
L. leaf infusion (BOLI) for an easier home-
based production. Wistar rats was induced by 
carrageenan to generate paw edema. Efficacy 
of BOLI compared to diclofenac and the most 
effective dosage were determined.
Methods
This experiment was conducted in the Animal 
Laboratory of Department of Pharmacology and Therapy in Dr. Hasan Sadikin General 
Hospital Bandung in October 2012. Bixa 
orellana L. leaves were procured from 
Lembang, Bandung, and were botanically 
identified at the Herbarium of Universitas Padjadjaran in Jatinangor. Thirty healthy 
female Wistar rats (2–3 months old) weighing 
± 200-50 g were used as subjects. All rats were housed in homogenous temperature and dark-
lighted cycle for 7 days with ad libitum access 
to food and drink. The rats were subsequently 
fasting for the next 24 hours to promote optimal 
inflammatory response. The procedure was 
done in accordance with the Russel and Burch’s 
principle of humane experimental techniques: 
reduction, refinement and  replacement (3R).5
The BOLI was prepared from dried Bixa 
orellana L. leaves weighed according to dosage 
and 100 mL of water for every treatment group. 
Mixed raw material was heated in an infusion 
pan for 15 minutes after the temperature 
reached 90˚Cwhile being stirred every 5 
minutes. Next, BOLI was filtered usingflannel 
fabric.Thirty millilitersof BOLIwere used for each rat in the treatment group receiving as 
much as 5 mL. Extra water was added to gain 
BOLI volume as required.6At one hour before treatment, basal 
right paw volume was quantified with a 
pletysmometer until lateral maleoluswhich 
was marked with a label sticker. Wistar rats 
were randomly divided into five groups. Group 
1 served as the negative group and was given 5 
mL aquades, three groups received BOLI with 
0.09 g; 0.18 g; and 0.36 g dosage respectively; 
and last group positive group was given 0.9 mg 
diclofenac. All treatments were given orally. 
An hour afterwards, edema was induced by carrageenan injection subcutaneously in sub 
plantar area of the posterior right paw. In 
order to alleviate the pain, all rats were locally 
anesthesized using 20 mg/kg BW of ketamine hydrochloride intraperitoneally prior to subcutaneous injection.
Paw edema volume changes were 
determined at 1, 2, 3, 4, 5, 6, and 24 hour (V1, 
V2, V3, V4, V5, V6, and V24) after treatment. 
Moreover, the efficacy of each treatment 
group to suppress paw edema was calculated 
compared to negative group. Results were 
classified into stadium 1 (% edema inhibition 
< 10% or poor), stadium 2 (% edema 
inhibition 10-15%or moderate), and stadium 
3 (% edema inhibition >15%or excellent). 
Data were statistically analysed using Kruskal-
Wallis and Mann-Whitney non-parametric 
tests when data distribution was not in normal 
distribution. The P value ≤ 0.05 was set to 
show significant difference.
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Results
As expected, negative group had the largest 
paw edema changes at 3 hour after treatment 
(1.36 mL) and the smallest paw edema changes 
were seen in group of rats given 0.18 g of BOLI 
at 24 hour after treatment (0,83 mL) (Table 1).
The group given 0.18 g of BOLI had the 
smallest mean paw edema changes. Data were 
then conversed into percentage. Paw volume in all groups gradually increased at 1 to 3 hour 
time point, and then started to fall afterwards. 
This proved the efficacy of carrageenan to optimally induce edema-forming effect at the 
first two hours after injection, after which 
was inhibited by both treatment groups and positive group.
Kruskal-Wallis test was exerted to 
identify the effect of various dosage of BOLI 
towards mean paw volume. Paw edema was 
significantlysuppressed at 2 and 6 hour after 
treatment (p < 0.05).
When compared to negative group, 
significant differences were not shown solely 
in group given 0.09 g of BOLI. In addition, 
significant difference among three dosages 
of BOLI (p < 0.05) was merely seen between 
groups given 0.18 g and 0.36 g of BOLI at 4 and 6 hour time points.
The group treated with 0.18 g of BOLI 
had the biggest inhibition (16.97%) followed 
closely by diclofenac (13.79%). Both groups 
did not show significant differences when 
compared using Mann-Whitney test.
Discussion
Anti-inflammatory effect in rats was examined 
by calculating suppression of paw edema as the simplest chemical method in the 
Animal Laboratory of the Department of 
Pharmacology and Therapy. Carrageenan was 
admintered as the inducer of inflammation 
due to its acute, non-immune, well-studied, 
and easily produced response. The efficacy 
of carrageenan was related to its biphasic 
course of reaction (Figure 1). The first phase 
was mediated by histamine, serotonin, 
5-hydroxytryptamine, and bradykininrelease lasting for 2 hours.7 The inability of Non-
steroidal Anti-inflammatory Drugs (NSAIDs), 
such as diclofenac, to intervene was because this phase did not comprise the activation 
of cyclooxygenase (COX) pathway. On the contrary, the second phase being manipulated 
was carried out by prostaglandin, protease, 
and lysosome production for as long as 3-5 hours, or even 24 hours after injection.8
Enhancement of paw edema at 1–3 hour 
time interval was also observed in the group 
treated with diclofenac. Due to its half life 
(1–2 hours), diclofenac attained optimal anti-
inflammatory effect at 2-3 hours after oral 
administration. It suppressed nitric oxide (NO) by altering the uptake and release of fatty acid responsible for the syntesis of arachidonic 
acid, the precursor of COX.2,9
Identical response also occured in the 
treatment groups. This can be explained by 
the ability of chemical constituents in BOLI, 
flavonoid and tannin, to block the second 
phase of carrageenan-induced inflammatory 
reaction.While flavonoid inhibited the 
production of COX-2 and inducible nitric oxide 
synthase (iNOS), tannin helped decrease 
reactive oxygen species (ROS) and free radicals concentration in the blood through 
its oxidation.10,11,12 Tannin is also capable of 
forming complex with protein, polysaccharide, alkaloid, nucleic acid, and mineral.13 Therefore, 
further study should be conducted to examine the effect of tannin administration topically to 
accelerate wound healing.
Different dosages of BOLI showed 
significantly different anti-inflammatory effect 
at 2 and 6 hour. After administration, flavonoid 
metabolites obtained maximal serum concentration at 1 hour and last for 4 hours. 
During that period, flavonoid concentration in 
Table 1 Paw Edema Volume Changes at Various Time Point
Group V0 V1 V2 V3 V4 V5 V6 V24 Mean + SD*1 0.66 1.15 1.28 1.36 1.31 1.33 1.25 0.96 1.162 0.61 1.05 1.16 1.25 1.13 1.11 1.08 0.90 1.033 0.56 1.00 1.01 1.16 1.06 1.11 0.98 0.83 0.964 0.61 1.01 1.10 1.30 1.26 1.23 1.18 0.91 1.07
5 0.68 1.00 1.00 1.20 1.18 1.11 1.05 0.90 1.01
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blood plasma is minimally altered.14 Factors 
that affect the time required for flavonoid to achieve its peak serum concentration include 
variation of food matrix and metabolism 
enzymes, causing disparities among efficacy in polyphenol absorption.15 On the other hand, 
it was assumed that the elimination of half 
life of BOLI was 6 hours after treatment with carrageenan. 
There was no significant differences 
between the group with 0.09 g of BOLI and 
the negative group. This might be explained 
due to dosage that was insufficient to attain optimal serum concentration.14 When comparing effects among treatment groups, 
only the group with 0.18 g and 0.36 g of BOLI 
displayed significant differenceat 4 and 6 hour 
after treatment. The group with 0.18 g of BOLI 
was most effective. Inefficiency of 0.36 g of 
BOLI might have occured due to the waning 
of its anti-inflammatory effect. However, this 
assumption should be verified in further studies.
Mean paw edema inhibition percentage 
clearly showed efficacy when groups were 
compared. No significant differences were 
found between 0.18 g of BOLI and the positive 
group. Thus, 0.18 g of BOLI was able to prevent 
paw volume from increasing which was comparable to diclofenac, rating stadium 3. 
On the contrary, the group with 0.09 g of BOLI 
was classified as stadium 2 and the group with 
0,36 g of BOLI was inclusive to stadium 1 as an 
anti-inflammatory agent.
These results provided scientific evidence 
for the benefit of Bixa orellana L. leaf used to 
counter disruptive effect of inflammation, in 
harmony with the prior study conducted by 
Keong et al.4 using extract of Bixa orellana L. 
leaf. Bixa orellana L. leaf in the form of both 
extract and infusion showed comparable anti-
inflammatory effect because the ratio between 
the plant and the diluent did not have significant impact to the chemical compounds contained 
within. In fact, chemical compositions in the leaf are mainly dependent on the temperature 
and duration of the extraction process.As conclusion, our present data suggested 
that Bixa orellana L. leaf infusion has an anti-
inflammatory effect that are comparable to 
diclofenac with the most effective dosage 
0.18 g equivalent 200 g body weight/day. Further studies may clarifty its potential as a 
topical anti-inflammatory agent as well as its 
probable toxic effect.
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